ArticleRheumatology (Oxford, England)2025

Cancer risk of Janus kinase inhibitors and biological disease-modifying antirheumatic drugs among older Americans with rheumatoid arthritis.

Shyfuddin Ahmed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.